If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Photodermatology, Photoimmunology & PhotomedicineVolume 16 Issue 6, Pages 250 - 255 Published Online: 5 Jan 2002 © 2010 John Wiley & Sons A/S The official publication of the Photomedicine Society, the British Photodermatology Group and the European Society of Photodermatology
Abstract | Full Text: PDF (Size: 112K) | Related Articles | Citation Tracking UVA protection efficacy of sunscreens can be determined by thepersistent pigment darkening (PPD) method (Part 2) Copyright Munksgaard 2000 KEYWORDS UVA • protection • sunscreens • evaluation • PPD ABSTRACTBackground: The UVA-induced Persistent Pigment Darkening (PPD) in vivo has been proposed as an end point for the evaluation of UVA protection. Aims:This study was designed to determine whether PPD can be used to correctly evaluate the in vivo effectiveness of UVA filters such as oxybenzone, avobenzone, ecamsule and zinc oxide concentrated and together with UVB filters. Methods: The UVA protection effectiveness of a number of commercial sunscreen products with either SPF 15 or SPF 30 was determined. Results: The UVA protection increased closely with the concentration of the UVA filters and was independent of UVB filters. The PPD method proved sensitive to all UVA filters irrespective of their range of absorbance within the UVA range. Conclusion: The results show PPD to be a stable end point inducible by all the UVA wavelengths, not affected by fluence rate, i.e. a reliable endogenous UVA dosimeter in the skin. |